Stephen Hansen, Director of Biopharma Intelligence at BioCentury, discusses innovative obesity therapies focusing on quality weight loss that preserves lean mass. Meanwhile, Lauren Martz, Executive Director of Biopharma Intelligence, dives into the potential impacts of Vinay Prasad's leadership at the FDA, particularly on regulatory approvals for biotech investors. They also introduce insights on ovarian cancer through large-scale molecular profiling, shedding light on predictive signatures that could enhance treatment strategies.
